Skip to main content
ArticleOPEN ACCESS

Serum miR-128 serves as a potential diagnostic biomarker for Alzheimer’s disease [Corrigendum] (Neuropsychiatr Dis Treat. 2021, 17, 269–275)

Neuropsychiatric Disease and Treatment
DOI: 10.2147/NDT.S306151
0Citations
Citations of this article
1Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Zhang M, Han W, Xu Y, Li D, Xue Q. Neuropsychiatr Dis Treat. 2021;17:269–275. The authors have advised there is an error in the author list on page 269. The author name “Ming Zhang” should read “Min Zhang”. The authors apologize for this error.

Cite

CITATION STYLE

APA

Serum miR-128 serves as a potential diagnostic biomarker for Alzheimer’s disease [Corrigendum] (Neuropsychiatr Dis Treat. 2021, 17, 269–275). (2021). Neuropsychiatric Disease and Treatment. Dove Medical Press Ltd. https://doi.org/10.2147/NDT.S306151

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free